BSE filing, NSE: ASTRAZEN. Summary written from the filing by ALFA Finder's alert engine.
AstraZeneca Pharma India Ltd: key numbers
- Share price
- ₹6,279.50
- Market cap
- ₹15,699 Cr
- Revenue (annual)
- ₹2,276 Cr
- Net profit (annual)
- ₹187.5 Cr
- P/E (TTM)
- 92.5×Sector 46.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AstraZeneca Pharma India Ltd
All →AstraZeneca Pharma India Capacity Expansion
AstraZeneca Pharma India inaugurated a new corporate office in Mumbai, covering 25,600 sq ft. This expansion strengthens the company's commercial operations and footprint in India.
- office space
- 25600.0 sq ft
AstraZeneca Pharma India Annual General Meeting
AstraZeneca Pharma India Ltd declared the voting results of its postal ballot, confirming the appointment and designation change of certain non-executive directors.
AstraZeneca Pharma India Other Announcement
NSE Sustainability Ratings and Analytics assigned AstraZeneca Pharma India an ESG rating of 73 for FY 2025-26. The rating was independently prepared without company engagement.
AstraZeneca Pharma India Legal & Regulatory
AstraZeneca Pharma India Limited received an order from the ROC, Bengaluru, imposing a total penalty of ₹0.03 Crore for a delayed filing. The company is evaluating next steps.
- Value
- ₹0.03 Cr
- From
- Registrar of Companies, Bengaluru, Karnataka
AstraZeneca Pharma India Legal & Regulatory
AstraZeneca Pharma disclosed a ₹1.88 lakh penalty from the Registrar of Companies due to a delay in filing Form MR-2.
- Value
- ₹0.02 Cr
AstraZeneca Pharma India Management Change
AstraZeneca Pharma India's Dr. Sandeep Arora resigned as Director, Medical Affairs, effective September 15, 2026. The company is seeking a suitable replacement for the position.
Other capacity expansion announcements
All →EPack Prefab Technologies Capacity Expansion: ₹100 Cr Investment
EPack Prefab plans to add 11,300 MT of PEB and 8,00,000 sq m of PUF capacity. The ₹100 Crore investment will be funded from IPO proceeds.
- Value
- ₹100.0 Cr
- Execution
- Period stated as 28-10-2026 in the filing (date as filed; the period is not otherwise defined)
- PEB structures capacity addition
- 11300.0 MTPA
EPack Prefab Technologies Capacity Expansion
Epack Prefab added 11,300 MTPA PEB and 8,00,000 sq m PUF capacity from October 28, 2026. The Rs.100 Crore project uses IPO net proceeds.
- PEB structures capacity addition
- 11300.0 MTPA
Ashiana Housing Capacity Expansion
Ashiana Housing signed a JDA for a Senior Living project on 4.41 acres in Gurugram. The 7.25 lakh sq. ft. area has estimated ₹1,300 Crore sales potential.
- saleable area of Senior Living project
- 725000 sq. ft.
Schneider Electric Infrastructure Capacity Expansion: ₹211 Cr Investment
Schneider Electric Infrastructure's board approved ₹211 Crore to expand KMVC facility capacity to 375,000 Vacuum Interrupters and add 18,000 Breakers per annum by FY 2028-29.
- Value
- ₹211.0 Cr
- Execution
- by end of FY 2028-29
- Vacuum Interrupter capacity at KMVC
- 375000 units per annum
KK Shah Hospitals Capacity Expansion
KK Shah Hospitals has commenced commercial operations of its 1.5T Siemens MRI scanner. This strengthens the company's diagnostic imaging infrastructure.
Senores Pharmaceuticals Capacity Expansion: ₹43 Cr Investment
Senores Pharmaceuticals disclosed capacity expansion at three subsidiaries with total estimated cost of ₹43 Crore. Expansions adding ~1.5 Bn units/annum are expected by March 2027.
- Value
- ₹43.00 Cr
- Execution
- By end of March 2027
- manufacturing capacity addition (per annum)
- 1502.7 Mn units